Toggle navigation
Home
Search
Services
Blog
Contact
About
Molecular Assay for Megakaryocyte Stimulating Factor
Murphy, Martin J.
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of a Photo-cleavable Agent for Reversible Protein Dimerization
Immunology, Inflammation, and Endometriosis
The role of glial cells in synapse remodeling in aging living mice
Opioid Regulation of GnRH Pulses
New Transgenic Tools for Studying Neural Circuit Formation
Recently added grants:
The Role of Tumor-Infiltrating Immune Cells and Estrogen Receptor Expression in Racial Disparities in Breast Cancer Biology.
Application of a humanized patient-derived xenograft mouse model to assess the preclinical efficacy of combined chemohyperthermia and chimeric TRAIL treatment in ovarian peritoneal carcinomatosis
Effects of opiates on neurons and their impact on HIV neuropathology
Optimizing Genetic Testing for Deafness for Clinical Diagnostics
Hair Cell Polarization and Sensory Bundle Development
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43DK047150-01
Application #
3496325
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1993-07-01
Project End
1993-12-31
Budget Start
1993-07-01
Budget End
1993-12-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Publications
Cheng, T; Erickson-Miller, C L; Li, C et al.
(1995)
HIMeg-1, a cell line derived from a CML patient, is capable of monocytic and megakaryocytic differentiation.
Leukemia 9:1257-63
Comments
Be the first to comment on Martin Murphy's grant